Anna Spencer > DLA Piper LLP (US) > Atlanta, United States > Lawyer Profile
DLA Piper LLP (US) Offices
![DLA Piper LLP (US) company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/908.jpg?v=1653316305)
ONE ATLANTIC CENTER
1201 WEST PEACHTREE STREET, SUITE 2800
ATLANTA, GA 30309-3450
GEORGIA
United States
- Firm Profile
- Go to...
Anna Spencer
![Anna Spencer photo](https://www.legal500.com/wp-content/uploads/sites/13/2020/07/anna.spencer_uhr-219x300.jpg)
Work Department
Technology Transactions and Strategic Sourcing; Healthcare
Position
Partner
Career
Anna Spencer focuses on the privacy, security and exchange of health information. She brings nearly twenty years of experience to bear when helping companies in the health care sector craft practical solutions to complex regulatory, public policy and enforcement matters that involve the processing of personal information. She counsels a diverse group of companies, including health plans, pharmaceutical and medical device manufacturers, healthcare providers, health information technology companies, digital health companies, pharmacies, electronic health record vendors, private equity companies, financial institutions and employers that sponsor group health plans.
She helps companies leverage data assets, respond to data breaches and advocate for simplified, common sense rules for the electronic exchange of health information. Anna regularly advises companies with respect to HIPAA, HITECH, Part 2 protections for substance abuse treatment records, GINA, the privacy and security rules promulgated by the Centers for Medicare & Medicaid Services (CMS), the Food and Drug Administration’s cybersecurity guidance for medical device companies and privacy requirements under the Common Rule. She also defends covered entities and business associates in investigations by the Office for Civil Rights, US Department of Health and Human Services (OCR). She lobbies Congress and federal agencies for changes to federal and state laws that govern the processing of health information.
Anna regularly assists clients on privacy and security compliance issues related to cloud computing, big data, health information technology, mobile applications, digital health, clinical trials, processing of bio-specimens and de-identification of data sets. She works closely with consultants that perform security risk assessments and compromise assessments. She also has extensive knowledge of state information privacy and security laws, including CMIA and CCPA. Anna co-authored a treatise on health information privacy and security for Bloomberg Law. She is a frequent speaker on a broad range of health care data privacy and security topics.
Memberships
Certified Information Privacy Professional (CIPP) by International Association of Privacy Professionals
Education
J.D., Vanderbilt University; B.A., Sewanee
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > International tax
- Real estate > Land use/zoning
- Investment fund formation and management > Alternative/hedge funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- International trade > CFIUS
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Insurance > Advice to insurers
- Industry focus > Cannabis
- Dispute resolution > E-discovery
- Tax > Financial products
- Finance > Fintech
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Antitrust > Cartel
- Intellectual property > Copyright
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: litigation
- Dispute resolution > General commercial disputes
- Government > Government contracts
- Dispute resolution > International arbitration
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Project finance
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- International trade > CFIUS
- Transport > Rail and road: litigation and regulation